Illinois Municipal Retirement Fund Increases Stock Position in Amdocs Limited $DOX

Illinois Municipal Retirement Fund boosted its position in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 46.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 149,539 shares of the technology company’s stock after purchasing an additional 47,537 shares during the period. Illinois Municipal Retirement Fund owned approximately 0.13% of Amdocs worth $12,270,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. LSV Asset Management boosted its holdings in Amdocs by 7.6% in the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock valued at $299,376,000 after purchasing an additional 257,193 shares during the last quarter. New York State Common Retirement Fund increased its holdings in Amdocs by 20.3% during the 3rd quarter. New York State Common Retirement Fund now owns 554,401 shares of the technology company’s stock worth $45,489,000 after purchasing an additional 93,527 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Amdocs by 13.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 266,124 shares of the technology company’s stock valued at $24,281,000 after purchasing an additional 31,827 shares in the last quarter. Alps Advisors Inc. boosted its stake in shares of Amdocs by 11.6% during the 3rd quarter. Alps Advisors Inc. now owns 237,883 shares of the technology company’s stock valued at $19,518,000 after buying an additional 24,771 shares during the last quarter. Finally, Foster & Motley Inc. grew its position in shares of Amdocs by 21.0% during the second quarter. Foster & Motley Inc. now owns 45,764 shares of the technology company’s stock worth $4,176,000 after buying an additional 7,934 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on DOX. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Stifel Nicolaus cut their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Finally, Barclays reduced their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Amdocs presently has an average rating of “Moderate Buy” and an average price target of $92.33.

Read Our Latest Stock Analysis on DOX

Amdocs Trading Down 2.5%

Shares of NASDAQ DOX opened at $68.33 on Friday. Amdocs Limited has a 12-month low of $66.67 and a 12-month high of $95.41. The company has a market cap of $7.38 billion, a price-to-earnings ratio of 13.22, a price-to-earnings-growth ratio of 1.24 and a beta of 0.40. The company has a current ratio of 1.06, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23. The stock’s 50 day simple moving average is $79.79 and its 200 day simple moving average is $81.90.

Amdocs (NASDAQ:DOXGet Free Report) last issued its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The firm had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period last year, the company earned $1.66 earnings per share. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities research analysts expect that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a $0.569 dividend. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.3%. Amdocs’s dividend payout ratio is currently 40.81%.

Amdocs Profile

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Featured Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.